Pomalidomide
Active substance: pomalidomide
CAPSULE · POMALIDOMIDE 4 mg/1
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- POMALIDOMIDE · 4 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 15 |
|
| EU 6 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-35b3-73a1-af34-deb6609f577f,01a120c3-43d0-747a-bcea-9d8b99ee1a91,01a120c3-4a34-7227-a88c-f0111801eeae,01a120c3-4f0d-7b0d-9829-731d69f5f11e,01a120c3-5259-74dd-8056-e13b9173dd53;count=14 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3be3-7094-a5fe-1a47653f3cc4,01a1208c-5e1b-792b-b01a-66efa61ac80a,01a1208c-80d4-7283-ba25-d6e693330646,01a1208c-8104-75b8-9bd9-d8ff40e91c43,01a1208d-0645-74c2-a04a-a2ae7eed9e57;count=47 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 59651-197
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 59651-197 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59651-197 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59651-197 · Verified 2026-10-09 · open in source